Innovus Pharma, an emerging pharmaceutical company with Dr. Bassam Damaj
Dr. Bassam Damaj, the President and CEO, and a member of the Board of Directors of Innovus Pharmaceuticals joins eHealth Radio and the Health Care Channel. (OTCBB: INNV). Headquartered in La Jolla, CA, Innovus Pharma is an emerging pharmaceutical company that develops, in-licenses, acquires and markets proprietary pharmaceutical products with unique packaging and presentation for better patient compliance and results.
Listen to interview [audio player below] with host Eric Michaels & guest Dr. Bassam Damaj discuss the following:
Before joining Innovus Pharma, Dr. Damaj served as President and Chief Executive Officer of Apricus Biosciences, Inc., (NASDAQ: APRI) from December 2009 until November 2012. At Apricus Bio, Dr. Damaj was responsible for the approval of its lead drug Vitaros, a treatment for erectile dysfunction. Dr. Damaj also signed multimillion dollar partnerships between Apricus Bio and leading pharmaceutical companies such as Abbott, Novartis-Sandoz and Takeda.
Related Web Site: www.innovuspharma.com
It is Free